Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amylin and amylin agonists for treating psychiatric diseases and disorders

Amylin and amylin agonists for treating psychiatric diseases and disorders

US Patent 8389477 · Granted Mar 5, 2013

Estimated economic value: $3,955,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucagon-receptor selective polypeptides and methods of use thereof2023
Methods comprising continuous administration of exenatide and co-administration 2023
Methods of treating cancer in pediatric patients2022
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2022
Glucagon-receptor selective polypeptides and methods of use thereof2022
Detection of rare sequence variants, methods and compositions therefor2021
Methods comprising continuous administration of a GLP-1 receptor agonist and co-2020
Bile acid recycling inhibitors for treatment of obesity and diabetes2020
Glucagon-receptor selective polypeptides and methods of use thereof2019
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2019
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2019
Methods of treating diabetes or obesity using bile acids, bile salts, and mimics2018